Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22813

Title: Sustained synchronized neuronal network activity in a human astrocyte co-culture system
Authors: Kuijlaars, Jacobine
Oyelami, Tutu
Diels, Annick
Rohrbacher, Jutta
Versweyveld, Sofie
Meneghello, Giulia
Tuefferd, Marianne
Verstraelen, Peter
Detrez, Jan R.
Verschuuren, Marlies
De Vos, Winnok H.
Meert, Theo
Peeters, Pieter J.
Cik, Miroslav
Nuydens, Rony
Brone, Bert
Verheyen, An
Issue Date: 2016
Citation: SCIENTIFIC REPORTS, 6 (Art N° 36529)
Abstract: Impaired neuronal network function is a hallmark of neurodevelopmental and neurodegenerative disorders such as autism, schizophrenia, and Alzheimer's disease and is typically studied using genetically modified cellular and animal models. Weak predictive capacity and poor translational value of these models urge for better human derived in vitro models. The implementation of human induced pluripotent stem cells (hiPSCs) allows studying pathologies in differentiated disease-relevant and patient-derived neuronal cells. However, the differentiation process and growth conditions of hiPSC-derived neurons are non-trivial. In order to study neuronal network formation and (mal) function in a fully humanized system, we have established an in vitro co-culture model of hiPSC-derived cortical neurons and human primary astrocytes that recapitulates neuronal network synchronization and connectivity within three to four weeks after final plating. Live cell calcium imaging, electrophysiology and high content image analyses revealed an increased maturation of network functionality and synchronicity over time for co-cultures compared to neuronal monocultures. The cells express GABAergic and glutamatergic markers and respond to inhibitors of both neurotransmitter pathways in a functional assay. The combination of this co-culture model with quantitative imaging of network morphofunction is amenable to high throughput screening for lead discovery and drug optimization for neurological diseases.
Notes: [Kuijlaars, Jacobine; Meert, Theo; Brone, Bert] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium. [Oyelami, Tutu; Diels, Annick; Rohrbacher, Jutta; Versweyveld, Sofie; Meneghello, Giulia; Tuefferd, Marianne; Meert, Theo; Peeters, Pieter J.; Cik, Miroslav; Nuydens, Rony; Verheyen, An] Janssen Res & Dev, B-2340 Beerse, Belgium. [Verstraelen, Peter; Detrez, Jan R.; Verschuuren, Marlies; De Vos, Winnok H.] Univ Antwerp, Dept Vet Sci, B-2020 Antwerp, Belgium. [De Vos, Winnok H.] Univ Ghent, Dept Mol Biotechnol, B-9000 Ghent, Belgium.
URI: http://hdl.handle.net/1942/22813
DOI: 10.1038/srep36529
ISI #: 000387043600001
ISSN: 2045-2322
Category: A1
Type: Journal Contribution
Validation: ecoom, 2017
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Published version3.58 MBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.